Literature DB >> 32714782

Clinical efficacy of mouth exercising devices in oral submucous fibrosis: A systematic review.

Shailesh M Gondivkar1, Amol R Gadbail2, Sachin C Sarode3, Rima S Gondivkar4, Shankargouda Patil5, Rahul N Gaikwad6, Monal Yuwanati7.   

Abstract

BACKGROUND: The management of oral submucous fibrosis (OSF) is primarily focused towards minimizing patient's symptoms and to prevent cancer development. Mouth exercise physiotherapy independently or in combination with other modalities is considered to be a mainstay for increasing the mouth opening (MO). The present systematic review was performed to identify different mouth exercising devices (MEDs) used and to provide detailed information on the fabrication and clinical efficacy of these devices among OSF patients.
METHODS: PubMed, Scopus, Web of Science, Google Scholar and CINAHL were searched for relevant literature until February 2019 and the information was extracted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. All full text papers describing use of MED in OSF patients were considered eligible.
RESULTS: Initial search resulted in 88 hits. After removing duplicates and screening of titles and abstracts, five papers that met the inclusion criteria were included. We identified five MEDs used for increasing the MO in OSF patients. Only one study administered additional treatment with topical steroids, oral antioxidants and ice-cream stick regime. The follow-up across studies ranged from 8 weeks to 6 months. Majority of the studies reported significant improvement in the MO without any relapse and side effects.
CONCLUSIONS: MED could play an important role in the management of OSF. Limited researches in this area suggest a dire need for the further investigations using randomized controlled trials.
© 2020 Craniofacial Research Foundation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Mouth exercising device; Oral physiotherapy; Oral submucous fibrosis

Year:  2020        PMID: 32714782      PMCID: PMC7371900          DOI: 10.1016/j.jobcr.2020.06.010

Source DB:  PubMed          Journal:  J Oral Biol Craniofac Res        ISSN: 2212-4268


  25 in total

1.  Novel mouth-exercising device for oral submucous fibrosis.

Authors:  Pravinkumar G Patil; Smita P Patil
Journal:  J Prosthodont       Date:  2012-07-10       Impact factor: 2.752

2.  A non-tooth-borne mouth-opening device for postoperative rehabilitation after surgical release of trismus.

Authors:  Frank Heller; Fu-Chan Wei; Yang-Ming Chang; Chi-Ying Tsai; Han-Tsung Liao; Chun-Li Lin; Yu-Chan Kuo
Journal:  Plast Reconstr Surg       Date:  2005-12       Impact factor: 4.730

3.  Limited mouth opening after primary therapy of head and neck cancer.

Authors:  Clemens Weber; Steffen Dommerich; Hans Wilhelm Pau; Burkhard Kramp
Journal:  Oral Maxillofac Surg       Date:  2010-09

Review 4.  A systematic review of medical interventions for oral submucous fibrosis and future research opportunities.

Authors:  A R Kerr; S Warnakulasuriya; A J Mighell; T Dietrich; M Nasser; J Rimal; A Jalil; M M Bornstein; T Nagao; F Fortune; V H Hazarey; P A Reichart; S Silverman; N W Johnson
Journal:  Oral Dis       Date:  2011-04       Impact factor: 3.511

5.  A preliminary report on the efficacy of a dynamic jaw opening device (dynasplint trismus system) as part of the multimodal treatment of trismus in patients with head and neck cancer.

Authors:  Michael D Stubblefield; Laura Manfield; Elyn R Riedel
Journal:  Arch Phys Med Rehabil       Date:  2010-08       Impact factor: 3.966

Review 6.  Review of drug treatment of oral submucous fibrosis.

Authors:  Revant H Chole; Shailesh M Gondivkar; Amol R Gadbail; Swati Balsaraf; Sudesh Chaudhary; Snehal V Dhore; Sumeet Ghonmode; Satish Balwani; Mugdha Mankar; Manish Tiwari; Rima V Parikh
Journal:  Oral Oncol       Date:  2011-12-27       Impact factor: 5.337

7.  Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis.

Authors:  Amol Ramchandra Gadbail; Minal Chaudhary; Madhuri Gawande; Alka Hande; Sachin Sarode; Satyajit Ashok Tekade; Sheetal Korde; Prajakta Zade; Rahul Bhowate; Rajiv Borle; Swati Patil
Journal:  J Oral Pathol Med       Date:  2017-02-28       Impact factor: 4.253

8.  Mouth-opening device as a treatment modality in trismus patients with head and neck cancer and oral submucous fibrosis: a prospective study.

Authors:  Yu-Hsuan Li; Wei-Chin Chang; Tien-En Chiang; Chiun-Shu Lin; Yuan-Wu Chen
Journal:  Clin Oral Investig       Date:  2018-04-26       Impact factor: 3.573

9.  The incidence of trismus and long-term impact on health-related quality of life in patients with head and neck cancer.

Authors:  Nina Pauli; Joakim Johnson; Caterina Finizia; Paulin Andréll
Journal:  Acta Oncol       Date:  2012-11-29       Impact factor: 4.089

10.  A New Intraoral Appliance for Trismus in Oral Submucous Fibrosis.

Authors:  Nallan C S K Chaitanya; C M S Krishna Prasad; Reshma Priyanka Danam; Madireddy Nithika; Chintada Suvarna; Jampala Nancypriyanka; Rajkumar Badam
Journal:  Case Rep Dent       Date:  2018-09-09
View more
  2 in total

1.  Management and Prognosis of Physical Therapy for the Post-Surgical Sequelae of Metastatic Cervical Lymphadenopathy.

Authors:  Sakina S Saifee; Shubhangi P Patil; Rupali B Thorat; Shivani S Lalwani; Tasneem M Lakkadsha
Journal:  Cureus       Date:  2022-08-04

Review 2.  Oral Submucous Fibrosis: A Review on Biomarkers, Pathogenic Mechanisms, and Treatments.

Authors:  Yen-Wen Shen; Yin-Hwa Shih; Lih-Jyh Fuh; Tzong-Ming Shieh
Journal:  Int J Mol Sci       Date:  2020-09-30       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.